- Home
- CMCL vs STXS Comparison
CMCL vs STXS Comparison
Compare CMCL & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCL
- STXS
- Stock Information
- Founded
- CMCL 1992
- STXS 1990
- Country
- CMCL Jersey
- STXS United States
- Employees
- CMCL N/A
- STXS N/A
- Industry
- CMCL Precious Metals
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CMCL Basic Materials
- STXS Health Care
- Exchange
- CMCL Nasdaq
- STXS Nasdaq
- Market Cap
- CMCL 181.6M
- STXS 189.8M
- IPO Year
- CMCL N/A
- STXS 2004
- Fundamental
- Price
- CMCL $9.33
- STXS $2.37
- Analyst Decision
- CMCL Buy
- STXS Strong Buy
- Analyst Count
- CMCL 1
- STXS 2
- Target Price
- CMCL $13.50
- STXS $4.50
- AVG Volume (30 Days)
- CMCL 71.4K
- STXS 361.5K
- Earning Date
- CMCL 11-11-2024
- STXS 11-11-2024
- Dividend Yield
- CMCL 4.49%
- STXS N/A
- EPS Growth
- CMCL N/A
- STXS N/A
- EPS
- CMCL 0.48
- STXS N/A
- Revenue
- CMCL $165,346,000.00
- STXS $25,143,000.00
- Revenue This Year
- CMCL $31.50
- STXS $1.16
- Revenue Next Year
- CMCL $9.45
- STXS $55.65
- P/E Ratio
- CMCL $19.35
- STXS N/A
- Revenue Growth
- CMCL 22.97
- STXS N/A
- 52 Week Low
- CMCL $8.91
- STXS $1.66
- 52 Week High
- CMCL $16.95
- STXS $3.29
- Technical
- Relative Strength Index (RSI)
- CMCL 33.99
- STXS 55.56
- Support Level
- CMCL $9.12
- STXS $2.21
- Resistance Level
- CMCL $9.93
- STXS $2.38
- Average True Range (ATR)
- CMCL 0.45
- STXS 0.15
- MACD
- CMCL 0.10
- STXS -0.01
- Stochastic Oscillator
- CMCL 12.59
- STXS 56.06
About CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.